Scout | PAR-23-267: Development of Novel Extracellular Vesicle-Based Therapeutic Platforms for Regenerative Medicine

This opportunity is no longer accepting applications.

grant PAR-23-267

Development of Novel Extracellular Vesicle-Based Therapeutic Platforms for Regenerative Medicine

Summary

This grant is for developing new technologies that use extracellular vesicles for regenerative medicine. It supports work on how to produce, manufacture, and use these vesicles as treatments.

This funding opportunity aims to support the development of novel extracellular vesicle-based therapeutic platforms for regenerative medicine. The focus is on platform-oriented technology development related to the production, manufacturing, and use of extracellular vesicles as therapeutics.

Funding Source

Agency: National Institutes of Health

Sub-agency: National Center for Advancing Translational Sciences

Program: SBIR

Phase: Phase II

Phase: Phase I

Awards & funding

Award Ceiling: $295,924

Award Amount: $295,924

Eligibility

Joint ventures of eligible U.S. Small Business Concerns – each venturer must independently meet SBIR/STTR ownership eligibility; joint ventures must have <50% participation by foreign business entities

Majority venture capital/hedge fund/private equity‑owned SBCs (SBIR only) – >50% owned by multiple VCOCs/hedge funds/private equity firms allowed for SBIR if no single such firm owns >50% unless that firm itself qualifies as a U.S. SBC

Only United States Small Business Concerns (SBCs) are eligible to apply as the applicant organization for this FOA.

SBC ownership/control requirements (at time of Phase I and Phase II award):

SBIR and STTR: More than 50% directly owned and controlled by one or more U.S. citiz…

Dates

Opportunity Released: April 18, 2023

Open for Submission: April 18, 2023

Submission Deadline: June 6, 2025

Application Window Closes: June 6, 2025

Supporting links

National Institutes of Health

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers